Evidence map›Paper›PMID 38730829›Full record

ArticleMaterials (Basel, Switzerland)2024

Investigation of Effect of Proposed Two-Stage Foam Injection Method and Modified Additive on Workability of Foam Concrete.

Rauan Lukpanov, Duman Dyussembinov, Aliya Altynbekova, Serik Yenkebayev, Adiya Zhumagulova

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rauan LukpanovSolid Research Group, LLP, Astana 010008, Kazakhstan.
Duman DyussembinovSolid Research Group, LLP, Astana 010008, Kazakhstan.
Aliya AltynbekovaSolid Research Group, LLP, Astana 010008, Kazakhstan.
Serik YenkebayevSolid Research Group, LLP, Astana 010008, Kazakhstan.
Adiya ZhumagulovaDepartment of Technology of Industrial and Civil Engineering, L.N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.ORCID 0000-0002-6310-2501

Funding

Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan AP13068424
6 · The paper itself

Abstract

This article presents the results of an investigation of the proposed method and the influence of a modified additive on foam concrete properties. X-ray diffraction analysis showed that the modified additive has a variable mineralogical composition, and the joint use of the components contributes to the synergistic effect, improving the processes of cement hydration. Microscopy of the foam concrete samples showed the presence of microcracks and micropores in samples both with and without the additive. However, the use of the additive significantly reduced their number and size, which indicates an improvement in the structure of the material. The strength values showed that the samples with the additive have high strength. In particular, the strength values of samples of type 3 at different stages of curing exceed those of samples of type 1 by 1.32-1.51 times and samples of type 2 by 1.07-1.10 times. The obtained strength values are 2.82-3.21 MPa for type 1, 3.64-4.04 MPa for type 2, and 4.39-4.84 MPa for type 3, which corresponds to grade D600. The evaluation of water absorption also confirmed the advantages of the proposed method and the additive, significantly reducing the water absorption of the samples and increasing their hydrophobicity. The obtained values of water absorption are 13.8-16.6% for type 1, 13.7-16.1% for type 2, and 9.5-11.2% for type 3.

Indexed as

blowing agentcompressive strengthfoam concretemicroscopic analysismicrosilicapost-alcohol bardwater absorptionX-ray diffraction analysis

Identifiers

PMID38730829
PMCPMC11084756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.